Chronic lymphocytic leukemia (CLL) is a B-cell disorder characterized by the monoclonal accumulation of CD5/CD23-positive lymphocytes at multiple sites [1,2,3] and a clinical heterogeneity [4,5] which has been correlated with different cytogenetic and molecular features of leukemic cells [6,7,8,9]. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.